Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6482796
SERIAL NO

09255245

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Improved therapeutic uses for N-terminal BPI protein products are described in patients that have BPI-reactive anti-neutrophil cytoplasmic antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XOMA CORPORATION2910 7TH STREET BERKELEY CALIFORNIA 94710 UNITED STATES OF AMERICA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carroll, Stephen Fitzhugh Walnut Creek, CA 10 28

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation